SLC25A21 and aceruloplasminemia: It has been proposed that loss of function of ODC, the protein encoded by SLC25A21, causes the human disease 2-oxoadipate acidaemia which is clinically characterised by hypotonia, seizures, motor and developmental delay, cerebellar ataxia and varying severities of intellectual disability [13], [14], [15], [16].